JFLLIFE — JFL Life Sciences Cashflow Statement
0.000.00%
Last trade - 00:00- IN₹356.03m
- IN₹564.45m
- IN₹1.31bn
Annual cashflow statement for JFL Life Sciences, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2022 March 31st | 2023 March 31st | C2024 March 31st | 2025 March 31st | 2026 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IAS | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 38 | 37.2 | 38 | 61.3 | 86.1 |
| Depreciation | |||||
| Non-Cash Items | 20.7 | 14.4 | 8.34 | 10.7 | 20.8 |
| Other Non-Cash Items | |||||
| Changes in Working Capital | -39.2 | -147 | 33.3 | -117 | -161 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 23.2 | -90.6 | 84.1 | -35.3 | -43.3 |
| Capital Expenditures | -16.9 | — | -61.1 | -3.95 | -33.8 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 9.8 | 8.6 | 0.264 | 3.85 | -5.66 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -7.1 | 8.6 | -60.9 | -0.104 | -39.4 |
| Financing Cash Flow Items | -20.8 | -14.3 | -8.6 | -10.8 | -20.3 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -14.6 | 80.7 | -23.5 | 35.4 | 91 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 1.5 | -1.3 | -0.252 | -0.002 | 8.29 |